반응식
[CH3:1][C:2]([CH3:26])=[CH:3][CH2:4][C:5]1[C:6]([OH:25])=[CH:7][C:8]([O:23]C)=[C:9]2[C:14](=[O:15])[CH2:13][CH:12]([C:16]3[CH:17]=[CH:18][C:19]([OH:22])=[CH:20][CH:21]=3)[O:11][C:10]=12>C(S([O-])(=O)=O)(F)(F)F.C(S([O-])(=O)=O)(F)(F)F.C(S([O-])(=O)=O)(F)(F)F.[Sc+3].C1COCC1>[CH3:1][C:2]([CH3:26])=[CH:3][CH2:4][C:5]1[C:10]2[O:11][C@H:12]([C:16]3[CH:17]=[CH:18][C:19]([OH:22])=[CH:20][CH:21]=3)[CH2:13][C:14](=[O:15])[C:9]=2[C:8]([OH:23])=[CH:7][C:6]=1[OH:25]참가 물질
4
실험 절차
To a mixture of isoxanthohumol (50 mg, 0.14 mmol), KI (34 mg, 0.21 mmol) and Sc(OTf)3 (105 mg, 0.21 mmol), 10 ml of THF are added and the solution is heated for 2.5 h under reflux. The mixture is stirred overnight at room temperature and concentrated in vacuum. The scandium salt is separated off via a short silica gel column (eluted with CHCl3/methanol=100:1). The resultant solution is concentrated to dryness in vacuum, the residue is taken up in CHCl3 and eluted through a silica gel column using CHCl3/-methanol=100:1. 8-Prenylnaringenin (formula (III) where R1=prenyl, R2=H) (44 mg, 92%) is obtained as a light-yellowish solid.
후처리
- additionare added
- temperaturethe solution is heated for 2.5 h
- temperatureunder reflux
- concentrationconcentrated in vacuum
- customThe scandium salt is separated off via a short silica gel column (eluted with CHCl3/methanol=100:1)
- concentrationThe resultant solution is concentrated to dryness in vacuum
- washeluted through a silica gel column
출처 및 근거
- ORD 기록
- ord-4784225c6fc94740bca3df471d39b4d1
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08067622B2
연결된 노트
불러오는 중…